litlas
ログインアカウント作成

Silvio Danese

1999–2025 年に発表

678
論文数
79,052
被引用数
141
h 指数
620
i10 指数

被引用数

Silvio Danese の年別被引用数1971 年: 被引用 1 件1993 年: 被引用 2 件1994 年: 被引用 1 件1997 年: 被引用 2 件2000 年: 被引用 2 件2001 年: 被引用 8 件2002 年: 被引用 11 件2003 年: 被引用 16 件2004 年: 被引用 23 件2005 年: 被引用 60 件2006 年: 被引用 66 件2007 年: 被引用 110 件2008 年: 被引用 144 件2009 年: 被引用 122 件2010 年: 被引用 167 件2011 年: 被引用 285 件2012 年: 被引用 205 件2013 年: 被引用 339 件2014 年: 被引用 388 件2015 年: 被引用 416 件2016 年: 被引用 494 件2017 年: 被引用 576 件2018 年: 被引用 600 件2019 年: 被引用 2,386 件2020 年: 被引用 3,443 件2021 年: 被引用 3,526 件2022 年: 被引用 3,281 件2023 年: 被引用 3,508 件2024 年: 被引用 5,620 件2025 年: 被引用 3,134 件2026 年: 被引用 84 件1972〜1992 年は被引用が無いため表示していません1995〜1996 年は被引用が無いため表示していません1998〜1999 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,888 件、この内訳の 17.8%中国: 引用元論文 3,440 件、この内訳の 12.5%イタリア: 引用元論文 2,018 件、この内訳の 7.4%イギリス: 引用元論文 1,796 件、この内訳の 6.6%カナダ: 引用元論文 1,335 件、この内訳の 4.9%ドイツ: 引用元論文 1,286 件、この内訳の 4.7%フランス: 引用元論文 1,281 件、この内訳の 4.7%スペイン: 引用元論文 872 件、この内訳の 3.2%オランダ: 引用元論文 856 件、この内訳の 3.1%日本: 引用元論文 725 件、この内訳の 2.6%ベルギー: 引用元論文 694 件、この内訳の 2.5%オーストラリア: 引用元論文 614 件、この内訳の 2.2%
0%17.8%その他 27.8%

機関

分野

  • Biochemistry, Genetics and Molecular Biology48.5%
  • Medicine34%
  • Immunology and Microbiology10%
  • Neuroscience1.7%
  • Agricultural and Biological Sciences1.1%
  • Nursing0.9%
  • その他3.8%

トピック

  • Inflammatory Bowel Disease14.8%
  • Gut microbiota and health4.8%
  • Microscopic Colitis4.6%
  • Rheumatoid Arthritis Research and Therapies2.2%
  • Autoimmune and Inflammatory Disorders1.7%
  • Biosimilars and Bioanalytical Methods1.7%
  • その他70.2%

共著者

全論文

検索で開く
  1. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD

    著者: Dan Turner, Amanda Ricciuto, Ayanna Lewis, Ferdinando D’Amico, Jasbir Dhaliwal, Anne M. Griffiths, Dominik Bettenworth, William J. Sandborn, Bruce E. Sands, Walter Reinisch, Jürgen Schölmerich, Willem A. Bemelman, Silvio Danese, Jean Yves Mary, David T. Rubin, Jean‐Frédéric Colombel, Laurent Peyrin‐Biroulet, Iris Dotan, María T. Abreu, Axel Dignaß - Gastroenterology 2021 被引用: 2,666

  2. Ulcerative colitis

    著者: Taku Kobayashi, Britta Siegmund, Catherine Le Berre, Shu Chen Wei, Marc Ferrante, Bo Shen, Charles N. Bernstein, Silvio Danese, Laurent Peyrin‐Biroulet, Toshifumi Hibi∥ - Nature Reviews Disease Primers 2020 被引用: 1,568

  3. Crohn’s disease

    著者: Giulia Roda, Siew C. Ng, Paulo Gustavo Kotze, Marjorie Argollo, Remo Panaccione, Antonino Spinelli, Arthur Kaser, Laurent Peyrin‐Biroulet, Silvio Danese - Nature Reviews Disease Primers 2020 被引用: 1,008

  4. Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis

    著者: Brian G. Feagan, Paul Rutgeerts, Bruce E. Sands, Stephen B. Hanauer, Jean‐Frédéric Colombel, William J. Sandborn, Gert Van Assche, Jeffrey Axler, Hyo Jong Kim, Silvio Danese, Irving H. Fox, Catherine Milch, Serap Sankoh, Tim Wyant, Jing Xu, Asit Parikh - New England Journal of Medicine 2013 被引用: 2,852

  5. Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis

    著者: William J. Sandborn, Chinyu Su, Bruce E. Sands, Geert D’Haens, Séverine Vermeire, Stefan Schreiber, Silvio Danese, Brian G. Feagan, Walter Reinisch, Wojciech Niezychowski, Gary S. Friedman, Nervin Lawendy, Dahong Yu, Deborah Woodworth, Arnab Mukherjee, Haiying Zhang, Paul J. Healey, Julián Panés - New England Journal of Medicine 2017 被引用: 1,727

  6. Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis

    著者: Bruce E. Sands, William J. Sandborn, Remo Panaccione, Christopher D. O’Brien, Hongyan Zhang, Jewel Johanns, Omoniyi J. Adedokun, Katherine Li, Laurent Peyrin‐Biroulet, Gert Van Assche, Silvio Danese, Stephan R. Targan, María T. Abreu, Tadakazu Hisamatsu, Philippe Szapary, Colleen Marano - New England Journal of Medicine 2019 被引用: 1,180

  7. Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials

    著者: Silvio Danese, Séverine Vermeire, Wen Zhou, Aileen L. Pangan, Jesse Siffledeen, Susan Greenbloom, Xavier Hébuterne, Geert D’Haens, Hiroshi Nakase, Julián Panés, Peter Higgins, Pascal Juillerat, James O. Lindsay, Edward V. Loftus, William J. Sandborn, Walter Reinisch, Minhu Chen, Yuri Sánchez González, Bidan Huang, Wangang Xie, John Liu, Michael Weinreich, Remo Panaccione - The Lancet 2022 被引用: 597

  8. Environmental Risk Factors for Inflammatory Bowel Diseases: An Umbrella Review of Meta-analyses

    著者: Daniele Piovani, Silvio Danese, Laurent Peyrin‐Biroulet, Georgios K. Nikolopoulos, Theodore Lytras, Stefanos Bonovas - Gastroenterology 2019 被引用: 788

  9. Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease

    著者: Raffaella Maria Gadaleta, Karel J. van Erpecum, Bas Oldenburg, Ellen C.L. Willemsen, Willem Renooij, Stefania Murzilli, Leo W. J. Klomp, Peter D. Siersema, M.E.I. Schipper, Silvio Danese, Giuseppe Penna, Gilles LAVERNY, Luciano Adorini, Antonio Moschetta, Saskia W. C. van Mil - Gut 2011 被引用: 851

  10. Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies

    著者: William J. Sandborn, Séverine Vermeire, Laurent Peyrin‐Biroulet, Marla C. Dubinsky, Julián Panés, Andrés Yarur, Timothy E. Ritter, Filip Baert, Stefan Schreiber, Sheldon Sloan, Fabio Cataldi, Kevin Shan, Christopher J. Rabbat, Michael Chiorean, Douglas C. Wolf, Bruce E. Sands, Geert D’Haens, Silvio Danese, Martina Goetsch, Brian G. Feagan - The Lancet 2023 被引用: 333

  11. Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis

    著者: William J. Sandborn, Brian G. Feagan, Geert D’Haens, Douglas C. Wolf, Igor Jovanović, Stephen B. Hanauer, Subrata Ghosh, AnnKatrin Petersen, Steven Y. Hua, Ji Hwan Lee, Lorna Charles, Denesh K. Chitkara, Keith Usiskin, Jean–Frédéric Colombel, Loren Laine, Silvio Danese - New England Journal of Medicine 2021 被引用: 532

  12. Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials

    著者: Geert D’Haens, Remo Panaccione, Filip Baert, Peter Bossuyt, Jean–Frédéric Colombel, Silvio Danese, Marla C. Dubinsky, Brian G. Feagan, Tadakazu Hisamatsu, Allen Lim, James O. Lindsay, Edward V. Loftus, Julián Panés, Laurent Peyrin‐Biroulet, Zhihua Ran, David T. Rubin, William J. Sandborn, Stefan Schreiber, Ezequiel Neimark, Alexandra Song, Kristina Kligys, Yinuo Pang, Valerie Pivorunas, Sofie Berg, W. Rachel Duan, Bidan Huang, Jasmina Kalabic, Xiaomei Liao, Anne Robinson, Kori Wallace, Marc Ferrante - The Lancet 2022 被引用: 387

  13. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target

    著者: Laurent Peyrin‐Biroulet, William J. Sandborn, Bruce E. Sands, Walter Reinisch, Willem A. Bemelman, Robert V. Bryant, Geert D’Haens, Iris Dotan, Marla C. Dubinsky, Brian G. Feagan, Gionata Fiorino, Richard B. Gearry, Suneeta Krishnareddy, Péter L. Lakatos, Edward V. Loftus, Philippe Marteau, Pia Munkholm, Travis B. Murdoch, Íngrid Ordás, Remo Panaccione, Robert H. Riddell, Joannie Ruel, David T. Rubin, Mark Samaan, Corey A. Siegel, Mark S. Silverberg, Jaap Stoker, S Schreiber, Simon Travis, Gert Van Assche, Silvio Danese, Julián Panés, Guillaume Bouguen, Sarah O’Donnell, Benjamin Pariente, Shawn Winer, Stephen B. Hanauer, J -F Colombel - The American Journal of Gastroenterology 2015 被引用: 1,838

  14. Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial

    著者: Brian G. Feagan, Silvio Danese, Edward V. Loftus, Séverine Vermeire, Stefan Schreiber, Timothy E. Ritter, Ronald Fogel, Rajiv Mehta, Sandeep Nijhawan, Radosław Kempiński, Rafał Filip, Ihor Hospodarskyy, Ursula Seidler, Frank Seibold, Ian Beales, Hyo Jong Kim, John McNally, Chohee Yun, Sally Zhao, Xiaopeng Liu, Chia‐Hsiang Hsueh, Chantal Tasset, R. Besuyen, Mamoru Watanabe, William J. Sandborn, Gerhard Rogler, Toshifumi Hibi∥, Laurent Peyrin‐Biroulet - The Lancet 2021 被引用: 437

  15. Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial

    著者: Jean‐Frédéric Colombel, Remo Panaccione, Peter Bossuyt, Milan Lukáš, Filip Baert, Tomáš Vaňásek, Ahmet Danalıoğlu, Gottfried Novacek, Alessandro Armuzzi, Xavier Hébuterne, Simon Travis, Silvio Danese, Walter Reinisch, William J. Sandborn, Paul Rutgeerts, Daniël W. Hommes, Stefan Schreiber, Ezequiel Neimark, Bidan Huang, Qian Zhou, Paloma Méndez, Joel Petersson, Kori Wallace, Anne Robinson, Roopal Thakkar, Geert D’Haens - The Lancet 2017 被引用: 912

  16. Efficacy and safety of biologics and small molecule drugs for patients with moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis

    著者: Juan S. Lasa, Pablo A. Olivera, Silvio Danese, Laurent Peyrin‐Biroulet - ˜The œLancet. Gastroenterology & hepatology 2021 被引用: 370

  17. Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial

    著者: Marc Ferrante, Remo Panaccione, Filip Baert, Peter Bossuyt, Jean–Frédéric Colombel, Silvio Danese, Marla C. Dubinsky, Brian G. Feagan, Tadakazu Hisamatsu, Allen Lim, James O. Lindsay, Edward V. Loftus, Julián Panés, Laurent Peyrin‐Biroulet, Zhihua Ran, David T. Rubin, William J. Sandborn, Stefan Schreiber, Ezequiel Neimark, Alexandra Song, Kristina Kligys, Yinuo Pang, Valerie Pivorunas, Sofie Berg, W. Rachel Duan, Bidan Huang, Jasmina Kalabic, Xiaomei Liao, Anne Robinson, Kori Wallace, Geert D’Haens - The Lancet 2022 被引用: 316

  18. IL-12 and IL-23 pathway inhibition in inflammatory bowel disease

    著者: Bram Verstockt, Azucena Salas, Bruce E. Sands, Clara Abraham, Haim Leibovitzh, Markus F. Neurath, Niels Vande Casteele, Silvio Danese, Geert D’Haens, Lars Eckmann, William A. Faubion, Brian G. Feagan, Vipul Jairath, Christopher Ma, Saurabh Mehandru, Julián Panés, Florian Rieder, William J. Sandborn, Mark S. Silverberg, Marisol Veny, Séverine Vermeire, Stefania Vetrano - Nature Reviews Gastroenterology & Hepatology 2023 被引用: 231

  19. Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial

    著者: Julián Panés, Damián García‐Olmo, Gert Van Assche, Jean‐Frédéric Colombel, Walter Reinisch, Daniel C. Baumgart, Axel Dignaß, Maria Nachury, Marc Ferrante, Lili Kazemi-Shirazi, Jean Charles Grimaud, Fernando de la Portilla, Eran Goldin, M Richard, Anne Leselbaum, Silvio Danese - The Lancet 2016 被引用: 1,064

  20. Revisiting fibrosis in inflammatory bowel disease: the gut thickens

    著者: Silvia D’Alessio, Federica Ungaro, Daniele Noviello, Sara Lovisa, Laurent Peyrin‐Biroulet, Silvio Danese - Nature Reviews Gastroenterology & Hepatology 2021 被引用: 233

  21. Inflammation and malnutrition in inflammatory bowel disease

    著者: Sara Massironi, Chiara Viganò, Andrea Palermo, Lorena Pirola, Giacomo Mulinacci, Mariangela Allocca, Laurent Peyrin‐Biroulet, Silvio Danese - ˜The œLancet. Gastroenterology & hepatology 2023 被引用: 280

  22. Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial

    著者: Bruce E. Sands, Peter M. Irving, Timothy Hoops, James Izanec, Long-Long Gao, Christopher Gasink, Andrew Greenspan, Matthieu Allez, Silvio Danese, Stephen B. Hanauer, Vipul Jairath, Tanja Kuehbacher, James D. Lewis, Edward V. Loftus, Emese Mihály, Remo Panaccione, Ellen Scherl, О. Б. Щукина, William J. Sandborn, Anita Afzali, Lilia Aitova, Xavier Aldeguer i Mante, Matthieu Allez, I Altorjay, Federico Argüelles‐Arias, Alessandro Armuzzi, Monika Augustyn, Mauro Bafutto, Jésus Barrio, Jakob Begun, Clint Behrend, Geert Bezemer, Guillaume Bonnaud, Marija Branković, Ik Jang Byung, Xavier Calvet, Karen A. Chachu, Júlio Maria Fonseca Chebli, Jae Hee Cheon, Halina Cichoż‐Lach, Larry Clark, Fraser Cummings, Kunal Dalal, Silvio Danese, Nanne K.H. de Boer, Maria de Lourdes Abreu Ferrari, Étienne Désilets, Predrag Dugalić, George Duvall, Olga Fedorishina, Rafał Filip, Cristina Flores, Ronald Fogel, James Fon, Michael Frankel, Keith Friedenberg, Walter Fries, Vassileva Galina, Piotr Gietka, Rishi Goel, Peter Hasselblatt, Hans Herfarth, László Herszényi, Pieter Hindryckx, Frank Hoentjen, Carmen Horjus Talabur Horje, Satish Iduru, Peter M. Irving, Robert J. Isfort, Vipul Jairath, Michael Jones, Dilara Kalimullina, Jeffry Katz, Manreet Kaur, Sunil K Khurana, Joo Sung Kim, Young‐Ho Kim, D Kleczkowski, Slavko Knezevic, Aaron Knoll, Louis Y Korman, Iskren Kotzev, Andrey Kulyapin, Kang‐Moon Lee, Desirée Leemreis, Jarosław Leszczyszyn, Jimmy K. Limdi, Jack J. Lissauer, Edward V. Loftus, Ewa Małecka‐Panas, John K. Marshall, Emese Mihály, Lukáš Milan, Giovanni Monteleone, Aleksandar Nagorni, Danuta Owczarek, Nichole Palekar, Remo Panaccione, Young Soo Park, Sang Hyoung Park ほか 43 名 - The Lancet 2022 被引用: 297

  23. Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis

    著者: Bruce E. Sands, Laurent Peyrin‐Biroulet, Edward V. Loftus, Silvio Danese, Jean–Frédéric Colombel, Murat Törüner, Laimas Jonaitis, Brihad Abhyankar, Jingjing Chen, Raquel Rogers, Richard A. Lirio, Jeffrey D. Bornstein, Stefan Schreiber - New England Journal of Medicine 2019 被引用: 725

  24. The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease

    著者: Loris Riccardo Lopetuso, S Deleu, Lihi Godny, Valentina Petito, Pierluigi Puca, Federica Facciotti, Harry Sokol, Gianluca Ianiro, Luca Masucci, María T. Abreu, Iris Dotan, Samuel P. Costello, Ailsa Hart, Tariq Iqbal, Sudarshan Paramsothy, Maurizio Sanguinetti, Silvio Danese, Herbert Tilg, Fabio Cominelli, Theresa T. Pizarro, Alessandro Armuzzi, Giovanni Cammarota, Antonio Gasbarrini, Séverine Vermeire, Franco Scaldaferri - Gut 2023 被引用: 123